Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Aoki, Tomokazu
182  Ergebnisse:
Personensuche X
?
1

Bevacizumab beyond Progression for Newly Diagnosed Glioblas..:

Nagane, Motoo ; Ichimura, Koichi ; Onuki, Ritsuko...
Cancers.  14 (2022)  22 - p. 5522 , 2022
Link: https://doi.org/10.3390/..
 
?
2

Predicting cerebral infarction in patients with atrial fibr..:

Nishi, Hidehisa ; Oishi, Naoya ; Ogawa, Hisashi...
Journal of Cerebral Blood Flow & Metabolism.  42 (2021)  5 - p. 746-756 , 2021
Link: https://doi.org/10.1177/..
 
?
3

Efficacy and safety of nivolumab in Japanese patients with ..:

Aoki, Tomokazu ; Kagawa, Naoki ; Sugiyama, Kazuhiko...
International Journal of Clinical Oncology.  26 (2021)  12 - p. 2205-2215 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Current Status of Palliative and Terminal Care for Patients..:

AOKI, Tomokazu ; NARITA, Yoshitaka ; MISHIMA, Kazuhiko.
Neurologia medico-chirurgica.  60 (2020)  12 - p. 600-611 , 2020
Link: https://doi.org/10.2176/..
 
?
5

Author's Response:

Kawabata, Noriyuki ; Hata, Akiko ; Aoki, Tomokazu
Journal of Pain and Symptom Management.  60 (2020)  2 - p. e107-e108 , 2020
Link: https://doi.org/10.1016/..
 
?
6

QOLP-07. HEALTH-RELATED QUALITY OF LIFE AND SYMPTOM BURDEN ..:

Tanaka, Shota ; Narita, Yoshitaka ; Mukasa, Akitake...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii176-ii176 , 2020
Link: https://doi.org/10.1093/..
 
?
7

Effect of Aromatherapy Massage on Quality of Sleep in the P..:

Kawabata, Noriyuki ; Hata, Akiko ; Aoki, Tomokazu
Journal of Pain and Symptom Management.  59 (2020)  6 - p. 1165-1171 , 2020
Link: https://doi.org/10.1016/..
 
?
8

CTNI-32. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CH..:

Aoki, Tomokazu ; Arakawa, Yoshiki ; Ueba, Tetsuya...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii49-ii50 , 2020
Link: https://doi.org/10.1093/..
 
?
9

ATIM-07. EFFICACY AND SAFETY OF NIVOLUMAB IN PATIENTS WITH ..:

Kagawa, Naoki ; Aoki, Tomokazu ; Sugiyama, Kazuhiko...
Neuro-Oncology.  21 (2019)  Supplement_6 - p. vi2-vi3 , 2019
Link: https://doi.org/10.1093/..
 
?
10

ACTR-01. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CH..:

Aoki, Tomokazu ; Arakawa, Yoshiki ; Ueba, Tetsuya...
Neuro-Oncology.  21 (2019)  Supplement_6 - p. vi12-vi12 , 2019
Link: https://doi.org/10.1093/..
 
?
11

ACTR-04. BIOMARK: A PHASE II STUDY OF BEVACIZUMAB BEYOND PR..:

Ichimura, Koichi ; Nagane, Motoo ; Kato, Mamoru...
Neuro-Oncology.  21 (2019)  Supplement_6 - p. vi12-vi13 , 2019
Link: https://doi.org/10.1093/..
 
?
12

NQPC-01 CURRENT STATUS AND PROBLEMS OF ADVANCE CARE PLANNIN..:

Matsutani, Masao ; Mishima, Kazuhiko ; Narita, Yoshitaka.
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii30-ii30 , 2019
Link: https://doi.org/10.1093/..
 
?
13

Predictors of Cardioembolic Stroke in Japanese Patients wit..:

Yasuda, Ken ; Fukuda, Shunichi ; Nakamura, Michikazu...
Cerebrovascular Diseases Extra.  8 (2018)  2 - p. 50-59 , 2018
Link: https://doi.org/10.1159/..
 
?
14

ACTR-62. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CH..:

Aoki, Tomokazu ; Arakawa, Yoshiki ; Ueba, Tetsuya...
Neuro-Oncology.  20 (2018)  suppl_6 - p. vi25-vi25 , 2018
Link: https://doi.org/10.1093/..
 
?
15

A randomized, double-blind, phase III trial of personalized..:

Narita, Yoshitaka ; Arakawa, Yoshiki ; Yamasaki, Fumiyuki...
Neuro-Oncology.  21 (2018)  3 - p. 348-359 , 2018
Link: https://doi.org/10.1093/..
 
1-15